Jerald Korn
Directeur des opérations chez EPIZYME, INC.
Profil
Jerald Korn is currently the Chief Operating Officer at Epizyme, Inc. and a Trustee at Solomon Schechter Day School of Greater Boston.
He previously worked as the Deputy Chief Compliance Officer at Millennium Pharmaceuticals, Inc., Associate General Counsel at Cubist Pharmaceuticals LLC, Compliance Officer & Associate General Counsel at AMAG Pharmaceuticals, Inc., Senior VP, Chief Legal & Administrative Officer at Tesaro, Inc., and Associate at Ropes & Gray LLP.
He also served as Secretary & Chief Administrative Officer at Kaleido Biosciences, Inc. for a brief period.
Mr. Korn received his undergraduate degree from Harvard University and his graduate degree from Boston University School of Law.
Postes actifs de Jerald Korn
| Sociétés | Poste | Début |
|---|---|---|
| EPIZYME, INC. | Directeur des opérations | 15/03/2022 |
| Solomon Schechter Day School of Greater Boston | Directeur/Membre du Conseil | - |
Anciens postes connus de Jerald Korn
| Sociétés | Poste | Fin |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Directeur Administratif | - |
| TESARO INC | Directeur Administratif | 01/07/2019 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/03/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2013 |
| AMAG PHARMACEUTICALS, INC. | Compliance Officer | 01/07/2011 |
Formation de Jerald Korn
| Harvard University | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Commercial Services |
| Solomon Schechter Day School of Greater Boston |